SLR Presents HBO Documentary Series on Alzheimer's

Posted on 05/06/2009
Back to news listings

Boston – Senior Living Residences (“SLR”), a Boston-based company with a reputation as a leader in providing Alzheimer’s care to New England seniors, has partnered with HBO in an ambitious grassroots public education campaign to shine a spotlight on Alzheimer’s disease. In an effort to inform the public, spur discussion, and excite individuals to participate in the search for a cure, SLR’s assisted living communities will air HBO’s groundbreaking four-part documentary series, The Alzheimer’s Project, for local audiences in private viewings in Boston, Cambridge, Concord and Methuen throughout the month of May.

The Alzheimer’s Project premieres on May 10th on HBO in association with the National Institute on Aging and the Alzheimer’s Association. The films are executive produced by Maria Shriver, the First Lady of California, whose father is currently battling Alzheimer’s.

“Senior Living Residences is proud to be a partner with HBO’s Alzheimer’s Project Coalition and to be among the select group of national organizations and individual companies working to advance Alzheimer’s education, care and research,” said Robert Larkin, President of SLR.

Senior Living Residences’ communities will screen the films and host follow-up discussions for the general public on the following dates:

The Memory Loss Tapes - An intimate look into the lives of seven individuals living with Alzheimer’s, each in an advancing state of dementia across the full spectrum of the progression of the disease. 

Wednesday, May 27 at 5:30pm at Concord Park, 68 Commonwealth Ave., Concord MA
Thursday, May 28 at 6:00pm at Methuen Village, 4 Gleason St., Methuen, MA

Grandpa, Do You Know Who I Am? - A film for children narrated by and featuring Maria Shriver that introduces viewers to seven children learning to understand and cope with their grandparent’s illness. 

Wednesday, May 27 at 7:00pm at Concord Park, 68 Commonwealth Ave., Concord MA

Caregivers - Seen through the lens of five individuals caring for family members suffering from the disease, this film conveys the sacrifices and successes of people who experience their loved ones’ gradual descent into dementia.
Tuesday, May 19 at 6:30pm at Neville Place, 650 Concord Ave., Cambridge, MA
Wednesday, May 27 at 6:00pm at Standish Village, 1190 Adams St., Boston, MA

Momentum in Science – A state-of-the science report that takes viewers inside the laboratories and clinics of 24 leading scientists and physicians, revealing some of the most cutting-edge research advances made in curing the disease.
Thursday, May 21 at 7:00pm at The Cambridge Homes, 360 Mount Auburn St.,
Cambridge, MA

Today, Alzheimer’s disease is the second most-feared illness in America, following cancer, and may affect as many as five million Americans. As the baby-boom generation reaches retirement, that number could soar to more than 11 million by 2040 and have a huge economic impact on America’s already fragile healthcare system. Regardless of age, race, ethnicity or sex, Alzheimer’s is an issue that touches us all. 

To view the four-part documentary series, click here.  

SLR manages five Memory Support Neighborhoods in eastern Massachusetts – The BayView and Standish Village in Boston; Concord Park in West Concord; Methuen Village in Methuen; and Neville Place in Cambridge. The cornerstone of SLR’s care approach is research-based innovation leading to the creation of services that are strategically designed to sustain cognitive function. SLR has put a variety of research-driven programs in place in its Alzheimer care communities, including diets that support memory function, extensive focus on social interaction and wellness, and pharmacological assessments, to provide residents with a level of high-quality care that is not found at other communities. Through SLR’s partnership with academic institutions, including the Boston University School of Medicine’s Alzheimer’s Disease Center, and allied professionals SLR continues to be an innovator in providing state-of-the-art care to individuals with Alzheimer’s disease and related dementia.